Ledger.Open graph →

SEC Form D · filed November 7, 2013

ReGenX Biosciences, LLC

Offering

$7.9M

Sold

$7.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WASHINGTON, Washington, D.C.

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Kenneth T. Mills · Washington, Washington, D.C.Exec · Director Kenneth T. Mills · Washington, Washington, D.C.Exec · Director Don Hayden · Washington, Washington, D.C.Director Allan Fox · Washington, Washington, D.C.Director Daniel Kiser · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗